Lausanne, Switzerland

Nicolas Guex

This inventor holds 1 USPTO granted patent. Top assignee: Université De Lausanne. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicolas Guex. Retrieved from https://idiyas.com/inventor/nicolas-guex

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Nicolas Guex

Introduction

Nicolas Guex is a prominent inventor based in Lausanne, Switzerland. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on adoptive immunotherapy, a promising approach to enhance the body's immune response against cancer.

Latest Patents

Nicolas Guex holds a patent for "Adoptive immunotherapy for treating cancer." This invention provides methods for producing and/or expanding tumor-infiltrating lymphocytes (TILs) that can be utilized in adoptive immunotherapy for cancer treatment. His innovative approach aims to improve the effectiveness of cancer therapies by harnessing the power of the immune system.

Career Highlights

Guex is affiliated with the Université de Lausanne, where he conducts his research and collaborates with other experts in the field. His dedication to advancing cancer treatment has positioned him as a key figure in the scientific community.

Collaborations

Nicolas Guex has worked alongside notable colleagues, including Marie-Agnes Doucey and Isaac Crespo. Their collaborative efforts contribute to the ongoing research and development in the field of immunotherapy.

Conclusion

Nicolas Guex's innovative work in adoptive immunotherapy represents a significant advancement in cancer treatment. His contributions continue to inspire further research and development in this critical area of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…